BackStrategic Trust - Kelly CRISPR & Gene Editing Technology ETF Overview

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Receivables

See how XDNA's receivables trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow
Receivables
N/A

Peer average

Loading

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Receivables History

Loading

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF vs. peers: Receivables Comparison

Loading

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF (XDNA) FAQ

Stockcircle tracks receivables for Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF (XDNA), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Receivables page is built for Strategic Trust - Kelly CRISPR & Gene Editing Technology ETF's historical receivables trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use receivables as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main XDNA overview so you can move from this figure to the surrounding analysis quickly.